Healthcare Policy Changes in Osteoporosis Can Improve Outcomes and Reduce Costs in the United States

被引:121
作者
Lewiecki, E. Michael [1 ]
Ortendahl, Jesse D. [2 ]
Vanderpuye-Orgle, Jacqueline [3 ]
Grauer, Andreas [3 ]
Arellano, Jorge [3 ]
Lemay, Jeffrey [3 ]
Harmon, Amanda L. [2 ]
Broder, Michael S. [2 ]
Singer, Andrea J. [4 ]
机构
[1] New Mexico Clin Res & Osteoporosis Ctr, Albuquerque, NM USA
[2] Partnership Hlth Analyt Res LLC, Beverly Hills, CA USA
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
[4] MedStar Georgetown Univ Hosp, Washington, DC USA
关键词
OSTEOPOROSIS; FRACTURE PREVENTION; FRACTURE RISK ASSESSMENT; GENERAL POPULATION STUDIES; HEALTH ECONOMICS;
D O I
10.1002/jbm4.10192
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the United States, osteoporosis affects over 10 million adults, has high societal costs ($22 billion in 2008), and is currently being underdiagnosed and undertreated. Given an aging population, this burden is expected to rise. We projected the fracture burden in US women by modeling the expected demographic shift as well as potential policy changes. With the anticipated population aging and growth, annual fractures are projected to increase from 1.9 million to 3.2 million (68%), from 2018 to 2040, with related costs rising from $57 billion to over $95 billion. Policy-driven expansion of case finding and treatment of at-risk women could lower this burden, preventing 6.1 million fractures over the next 22 years while reducing payer costs by $29 billion and societal costs by $55 billion. Increasing use of osteoporosis-related interventions can reduce fractures and result in substantial cost-savings, a rare and fortunate combination given the current landscape in healthcare policy. (C) 2019 The Authors. JBMR Plus published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research.
引用
收藏
页数:7
相关论文
共 46 条
  • [21] Lifetime absolute risk of hip and other osteoporotic fracture in Belgian women
    Hiligsmann, Mickael
    Bruyere, Olivier
    Ethgen, Olivier
    Gathon, Henry-Jean
    Reginster, Jean-Yves
    [J]. BONE, 2008, 43 (06) : 991 - 994
  • [22] Underutilization of antiosteoporotic drugs by orthopedic surgeons for prevention of a secondary osteoporotic fracture
    Iba, Kousuke
    Takada, Junichi
    Hatakeyama, Naoko
    Kaya, Mitsunori
    Isogai, Satoshi
    Tsuda, Hajime
    Obata, Hiroyuki
    Miyano, Suichi
    Yamashita, Toshihiko
    [J]. JOURNAL OF ORTHOPAEDIC SCIENCE, 2006, 11 (05) : 446 - 449
  • [23] Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis
    Imaz, I.
    Zegarra, P.
    Gonzalez-Enriquez, J.
    Rubio, B.
    Alcazar, R.
    Amate, J. M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 (11) : 1943 - 1951
  • [24] Fracture Reduction Affects Medicare Economics (FRAME): Impact of increased osteoporosis diagnosis and treatment
    King, AB
    Saag, KG
    Burge, RT
    Pisu, M
    Goel, N
    [J]. OSTEOPOROSIS INTERNATIONAL, 2005, 16 (12) : 1545 - 1557
  • [25] Medicare Payment Cuts For Osteoporosis Testing Reduced Use Despite Tests' Benefit In Reducing Fractures
    King, Alison B.
    Fiorentino, Donna M.
    [J]. HEALTH AFFAIRS, 2011, 30 (12) : 2362 - 2370
  • [26] Kluwer Wolters, 2018, PRICE RX
  • [27] The health and economic consequences of osteopenia- and osteoporosis-attributable hip fractures in Germany: estimation for 2002 and projection until 2050
    Konnopka, A.
    Jerusel, N.
    Koenig, H.-H.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 (07) : 1117 - 1129
  • [28] Impact of a primary care physician workshop on osteoporosis medical practices
    Laliberte, M. -C.
    Perreault, S.
    Dragomir, A.
    Goudreau, J.
    Rodrigues, I.
    Blais, L.
    Damestoy, N.
    Corbeil, D.
    Lalonde, L.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2010, 21 (09) : 1471 - 1485
  • [29] Leader D, 2017, OSTEOPOROSIS RELATED
  • [30] FRAX for fracture prediction shorter and longer than 10 years: the Manitoba BMD registry
    Leslie, W. D.
    Majumdar, S. R.
    Morin, S. N.
    Lix, L. M.
    Johansson, H.
    Oden, A.
    McCloskey, E. V.
    Kanis, J. A.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 (09) : 2557 - 2564